계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
SaNOtize
company
About
SaNOtize is a biotech company using a platform technology for topical to treat upper respiratory and dermal infections.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $24M
- Industries
- Biotechnology,Life Science,Medical
- Founded date
- Jan 1, 2017
- Number Of Employee
- 1 - 10
- Operating Status
- Active
SaNOtize is a biotech company using a platform technology for topical to treat upper respiratory and dermal infections. The company develops a Nitric Oxide Releasing Solution platform technology to treat and prevent microbial infections, including drug resistant microbes. Its target indications include treatment for strep throat, athlete's foot, infected wounds, diabetic foot ulcers, sinusitis, cold and flu, and others.SaNOtize was founded in 2017 by Gilly Regev and Chris Miller and it is headquartered in Vancouver, British Columbia.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$24M
SaNOtize has raised a total of
$24M
in funding over 2 rounds. Their latest funding was raised on
Aug 24, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 24, 2022 | Series B | $24M | 2 |
OurCrowd
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
SaNOtize is funded by 2 investors.
OurCrowd
and Agricultural Bank of China
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
OurCrowd
|
Yes | Series B |
Agricultural Bank of China
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
